✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals
Market Cap
₹11 Cr.
P/E
82.38
  • Link Pharma Chem
  • Beryl Drugs
  • Parmax Pharma

FAQs on Link Pharma Chem Ltd. Shareprice

Link Pharma Chem has given lower returns compared to its competitors.
Link Pharma Chem has grown at ~-12.3% over the last 4yrs while peers have grown at a median rate of 11.99%

Link Pharma Chem is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Link Pharma Chem is 82.38, while 3 year average PE is 20.32.
Also latest EV/EBITDA of Link Pharma Chem is 12.04 while 3yr average is 22.48.

Growth Table

  • Link Pharma Chem Ltd.
  • Beryl Drugs
  • Parmax Pharma

Balance Sheet

  • Link Pharma Chem Ltd.
  • Beryl Drugs
  • Parmax Pharma

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Link Pharma Chem Ltd.
  • Beryl Drugs
  • Parmax Pharma

Cash Flow

  • Link Pharma Chem Ltd.
  • Beryl Drugs
  • Parmax Pharma

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Link Pharma Chem Ltd.
  • Beryl Drugs
  • Parmax Pharma

Quarterly Results

  • Link Pharma Chem Ltd.
  • Beryl Drugs
  • Parmax Pharma

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*

FAQs on Link Pharma Chem Ltd. Financials

Balance sheet of Link Pharma Chem is moderately strong, But short term working capital might become an issue for this company.

Yes, The net debt of Link Pharma Chem is increasing.
Latest net debt of Link Pharma Chem is ₹6.53 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹5.72 Crs.

The profit is oscillating.
The profit of Link Pharma Chem is -₹1.03 Crs for Mar 2025, -₹1.36 Crs for Mar 2024 and ₹0.65 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Link Pharma Chem latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery and unproductive assets like Cash & Short Term Investments, Capital Work in Progress, Inventory, Accounts Receivable, Short Term Loans & Advances

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech